Blockade of the CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Blockade of the CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapy
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 13, Issue 604, Pages eabc8922
Publisher
American Association for the Advancement of Science (AAAS)
Online
2021-07-29
DOI
10.1126/scitranslmed.abc8922
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting PD-1 or PD-L1 in Metastatic Kidney Cancer - Combination Therapy in the First Line Setting
- (2020) David H Aggen et al. CLINICAL CANCER RESEARCH
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial
- (2019) Vicky Makker et al. LANCET ONCOLOGY
- Potential Role of HMGCS2 in Tumor Angiogenesis in Colorectal Cancer and Its Potential Use as a Diagnostic Marker
- (2019) Kejian Zou et al. Canadian Journal of Gastroenterology and Hepatology
- Multimerin-2 maintains vascular stability and permeability
- (2019) Rosanna Pellicani et al. MATRIX BIOLOGY
- Assessment of Combined Nivolumab and Bevacizumab in Relapsed Ovarian Cancer
- (2019) Joyce F. Liu et al. JAMA Oncology
- Transcriptome analysis of human brain microvascular endothelial cells response to Neisseria meningitidis and its antigen MafA using RNA-seq
- (2019) Evelína Káňová et al. Scientific Reports
- Single-Cell Transcriptome Analyses Reveal Endothelial Cell Heterogeneity in Tumors and Changes following Antiangiogenic Treatment
- (2018) Qi Zhao et al. CANCER RESEARCH
- CD93 promotes β1 integrin activation and fibronectin fibrillogenesis during tumor angiogenesis
- (2018) Roberta Lugano et al. JOURNAL OF CLINICAL INVESTIGATION
- Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
- (2018) Dai Fukumura et al. Nature Reviews Clinical Oncology
- Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
- (2018) Mark A. Socinski et al. NEW ENGLAND JOURNAL OF MEDICINE
- TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
- (2018) Sanjeev Mariathasan et al. NATURE
- A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
- (2018) Miguel F. Sanmamed et al. CELL
- Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3
- (2018) Jun Wang et al. CELL
- EndoDB: a database of endothelial cell transcriptomics data
- (2018) Shawez Khan et al. NUCLEIC ACIDS RESEARCH
- CD28H expression identifies resident memory CD8 + T cells with less cytotoxicity in human peripheral tissues and cancers
- (2018) Yu Tian et al. OncoImmunology
- Dissecting the CD93-Multimerin 2 interaction involved in cell adhesion and migration of the activated endothelium
- (2017) Federico Galvagni et al. MATRIX BIOLOGY
- Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming
- (2017) Lin Tian et al. NATURE
- GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
- (2017) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface
- (2017) K A Khan et al. ONCOGENE
- Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade
- (2017) Martina Schmittnaegel et al. Science Translational Medicine
- Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation
- (2017) Elizabeth Allen et al. Science Translational Medicine
- Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation
- (2017) Veronica Huber et al. SEMINARS IN CANCER BIOLOGY
- Acute tumour response to a bispecific Ang-2-VEGF-A antibody: insights from multiparametric MRI and gene expression profiling
- (2016) Lauren CJ Baker et al. BRITISH JOURNAL OF CANCER
- Normalization of Tumor Vessels by Tie2 Activation and Ang2 Inhibition Enhances Drug Delivery and Produces a Favorable Tumor Microenvironment
- (2016) Jin-Sung Park et al. CANCER CELL
- Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
- (2016) Willy Hugo et al. CELL
- CD93 and dystroglycan cooperation in human endothelial cell adhesion and migration
- (2016) Federico Galvagni et al. Oncotarget
- Elevated Expression of the C-Type Lectin CD93 in the Glioblastoma Vasculature Regulates Cytoskeletal Rearrangements That Enhance Vessel Function and Reduce Host Survival
- (2015) Elise Langenkamp et al. CANCER RESEARCH
- Targeting the tumor vasculature to enhance T cell activity
- (2015) Evripidis Lanitis et al. CURRENT OPINION IN IMMUNOLOGY
- CD93 gene polymorphism is associated with disseminated colorectal cancer
- (2015) Renate S. Olsen et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Semaphorin 3D autocrine signaling mediates the metastatic role of annexin A2 in pancreatic cancer
- (2015) Kelly Foley et al. Science Signaling
- Immunological mechanisms of the antitumor effects of supplemental oxygenation
- (2015) Stephen M. Hatfield et al. Science Translational Medicine
- Endothelial destabilization by angiopoietin-2 via integrin β1 activation
- (2015) Laura Hakanpaa et al. Nature Communications
- Semaphorin 3D autocrine signaling mediates the metastatic role of annexin A2 in pancreatic cancer
- (2015) Kelly Foley et al. Science Signaling
- Insulin-like growth factor binding protein-related protein 1 and cancer
- (2014) Shuzhen Zhu et al. CLINICA CHIMICA ACTA
- Angiomodulin, a marker of cancer vasculature, is upregulated by vascular endothelial growth factor and increases vascular permeability as a ligand of integrinαvβ3
- (2014) Eriko Komiya et al. Cancer Medicine
- Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment
- (2014) Theerawut Chanmee et al. Cancers
- A Core Human Primary Tumor Angiogenesis Signature Identifies the Endothelial Orphan Receptor ELTD1 as a Key Regulator of Angiogenesis
- (2013) Massimo Masiero et al. CANCER CELL
- Vascular Normalization as an Emerging Strategy to Enhance Cancer Immunotherapy
- (2013) Y. Huang et al. CANCER RESEARCH
- Benefits of Vascular Normalization Are Dose and Time Dependent--Letter
- (2013) Y. Huang et al. CANCER RESEARCH
- Identification and Analysis of In Vivo VEGF Downstream Markers Link VEGF Pathway Activity with Efficacy of Anti-VEGF Therapies
- (2013) M. J. Brauer et al. CLINICAL CANCER RESEARCH
- Anti-VEGF- and anti-VEGF receptor-induced vascular alteration in mouse healthy tissues
- (2013) Y. Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- B7-H5 costimulates human T cells via CD28H
- (2013) Yuwen Zhu et al. Nature Communications
- CD93: Recent Advances and Implications in Disease
- (2012) Mallary C. Greenlee-Wacker et al. CURRENT DRUG TARGETS
- The Epidermal Growth Factor-like Domain of CD93 Is a Potent Angiogenic Factor
- (2012) Yuan-Chung Kao et al. PLoS One
- Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy
- (2012) Y. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IGFBP7 Binds to the IGF-1 Receptor and Blocks Its Activation by Insulin-Like Growth Factors
- (2012) V. Evdokimova et al. Science Signaling
- Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
- (2012) J. M. Taube et al. Science Translational Medicine
- VEGF masks BNIP3-mediated apoptosis of hypoxic endothelial cells
- (2011) Paul Jurasz et al. ANGIOGENESIS
- High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq
- (2011) J. Schodel et al. BLOOD
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- Molecular control of endothelial cell behaviour during blood vessel morphogenesis
- (2011) Shane P. Herbert et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Heparan Sulfate Proteoglycans
- (2011) S. Sarrazin et al. Cold Spring Harbor Perspectives in Biology
- Angiopoietin-2 Interferes with Anti-VEGFR2-Induced Vessel Normalization and Survival Benefit in Mice Bearing Gliomas
- (2010) S.-S. Chae et al. CLINICAL CANCER RESEARCH
- The Collagen Family
- (2010) S. Ricard-Blum Cold Spring Harbor Perspectives in Biology
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
- (2009) M. D. Robinson et al. BIOINFORMATICS
- Secreted Frizzle-Related Protein 2 Stimulates Angiogenesis via a Calcineurin/NFAT Signaling Pathway
- (2009) A. Courtwright et al. CANCER RESEARCH
- Angiomodulin Is a Specific Marker of Vasculature and Regulates Vascular Endothelial Growth Factor-A–Dependent Neoangiogenesis
- (2009) Andrea T. Hooper et al. CIRCULATION RESEARCH
- Novel Roles of GATA1 in Regulation of Angiogenic Factor AGGF1 and Endothelial Cell Function
- (2009) Chun Fan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Oncogenic BRAF Induces Senescence and Apoptosis through Pathways Mediated by the Secreted Protein IGFBP7
- (2008) Narendra Wajapeyee et al. CELL
- Vascular normalization in Rgs5-deficient tumours promotes immune destruction
- (2008) Juliana Hamzah et al. NATURE
- Glioblastoma-secreted factors induce IGFBP7 and angiogenesis by modulating Smad-2-dependent TGF-β signaling
- (2008) A Pen et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now